Hologic Current Deferred Revenue from 2010 to 2025
| HOLX Stock | USD 74.10 0.05 0.07% |
Current Deferred Revenue | First Reported 2001-03-31 | Previous Quarter 212.7 M | Current Value 199.7 M | Quarterly Volatility 72.9 M |
Check Hologic financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Hologic's main balance sheet or income statement drivers, such as Depreciation And Amortization of 155.5 M, Interest Expense of 76.2 M or Total Revenue of 4.3 B, as well as many indicators such as Price To Sales Ratio of 4.76, Dividend Yield of 0.0 or PTB Ratio of 4.09. Hologic financial statements analysis is a perfect complement when working with Hologic Valuation or Volatility modules.
Hologic | Current Deferred Revenue | Build AI portfolio with Hologic Stock |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Hologic Stock Analysis
When running Hologic's price analysis, check to measure Hologic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hologic is operating at the current time. Most of Hologic's value examination focuses on studying past and present price action to predict the probability of Hologic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hologic's price. Additionally, you may evaluate how the addition of Hologic to your portfolios can decrease your overall portfolio volatility.